Comparing two types of radiation therapy for spinal cancer
Official title: Prospective Registry Trail COMparing Stereotactic Body Radiotherpy (SBRT) to Conventional PAlliative RadioTherapy (CRT) in Patients With Spinal Metastases
Run by University Health Network, Toronto · NCT05589701 · Data updated 2026-11-12
This study is testing whether a newer type of radiation therapy for spinal cancer works better than the traditional method to help patients manage their pain and improve their survival.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | December 12, 2022 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | March 5, 2026 |
| Trial ID | NCT05589701 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with painful spinal metastases who can receive radiation treatment.
✕Probably not a fit
Patients with prior overlapping radiotherapy or those with lymphoma, myeloma, or germ cell malignancies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to compare the effectiveness of stereotactic body radiation therapy (SBRT) versus conventional radiation therapy (CRT) in patients with spinal metastases. Researchers will gather data on radiation oncologists' decision-making processes through questionnaires and analyze real-world outcomes such as local progression, pain response, and overall survival rates. The goal is to develop an evidence-based algorithm to aid future medical decisions for patients with similar conditions.
Why it matters
Potential benefit: If successful, this study could provide insights that lead to improved treatment strategies for patients with spinal metastases.
How similar studies have gone: Other studies have explored similar comparisons between SBRT and CRT, indicating potential for meaningful insights, though this specific approach is registry-based and may offer novel data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults 18 years of age or older. * Patients seen at the Princess Margaret Cancer Centre with painful spinal metastases amenable to radiation treatment. * Confirmation of diagnosis: a) Known/documented prior histological cancer diagnosis * Able to provide written consent * ECOG performance status 0-3 Exclusion Criteria: * Prior radiotherapy, with fields overlapping, resulting in excessive doses to organs at risk * Lymphoma, myeloma or germ cell malignancies
Where it's running
-
University Health Network
Toronto, Ontario, Canada Recruiting
Study contacts
- Study coordinator: David Shultz, MD
- Email: david.shultz@rmp.uhn.ca
- Phone: 416-946-4501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stereotactic body radiation therapy for spinal metastases with epidural compression
This study tests whether SBRT can safely help adults with spinal metastases that compress the spinal cord see if the treatment works in reducing issues from their cancer.
-
Postoperative Edge SBRT for Spinal Metastases
This observational study tests whether high-precision postoperative SBRT with the Edge system can improve local control and neurological outcomes in patients with spinal metastases after surgery.
-
Radiotherapy after Separation Surgery for Spinal Metastases
This study tests whether giving radiotherapy after separation surgery helps people with spinal metastases live longer and feel better.
-
Focused high-dose SBRT for spinal tumors
This program will try focused high-dose SBRT for adults with spinal metastases to track side effects and local tumor control during routine care.
-
Pre-surgery focused radiation for spinal metastases.
This trial will test whether short-course, focused radiation given before surgery can improve local tumor control and reduce pain and disability in adults with spinal metastases.
-
Evaluating autologous blood transfusion in spinal surgery for lung cancer with spinal metastasis
This study is testing whether using a patient's own blood during spinal surgery for lung cancer with spinal metastases is safer and more effective than using donated blood.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.